Categories Analysis, Other Industries
How Ford stumbled and tumbled in China over the past three years
Ford Motor Company (NYSE: F) recently reported a sales decline in China, its second-biggest market, for three years in a row. After a strong performance in the region in 2016, things seem to have gone pretty much downhill.
Back in 2016, Ford posted record annual sales in China of 1.27 million vehicles, which was up 14% from 2015. The company saw solid demand for its lineup of SUVs such as Ford Edge, Ford Explorer, the Ford Taurus large car and the Ford Mustang. The demand for Ford Edge jumped 123% during the year. Lincoln’s sales grew around three-fold from 2015, supported by demand for Lincoln SUVs and the growing number of dealerships.
In 2017, annual sales in China dropped 6% to just under 1.2 million vehicles compared to 2016. Although Ford saw challenges in the passenger vehicle segment during the first half of the year, it witnessed strong sales for its Ford Escort and Mondeo vehicles in the second half. Lincoln sales increased 66% from the previous year.
During 2017, the auto industry in China witnessed excess capacity at 57% of production. Ford’s market share in the country decreased slightly to 4.2% due to increased competition, particularly in the SUV segment. The negative industry pricing also caused a decline in net income margin.
Also read: Ford Motor Company (F): A look at major restructuring and growth activities
In 2018, China sales further dipped to just over 752,000 vehicles, down almost 37% from the previous year. This was mainly due to lower sales at Changan Ford Automobile (CAF) as excess stocks led to heavy discounts and lower dealer profits. Lincoln saw a 2.2% increase over 2017. During 2018, the auto industry in China saw excess capacity at 78% of production.
In 2019, Ford sold just around 568,000 vehicles in China, reflecting a drop of 26.1% from the previous year. Even Lincoln’s annual sales fell 15.7% to 46,629 units versus the previous year.
Ford stated that it expects to face pressures from the external environment and to see industry volume decline in 2020. The company is looking to improve its product lineup with more customer-centric products in order to reduce the external pressure and increase dealers’ profitability. In short, the road ahead does not seem smooth for the company in China.
Most Popular
Earnings Preview: Johnson & Johnson bets on innovation to stay in growth mode
Over the years, Johnson & Johnson (NYSE: JNJ) has remained a dominant player in the medical industry, benefitting from its unique business model and growth strategy focused on constant innovation.
Key takeaways from PepsiCo’s Q3 2024 earnings report
Shares of PepsiCo, Inc. (NASDAQ: PEP) gained over 1% on Tuesday even though the company delivered mixed results for the third quarter of 2024 and lowered its guidance for the
PEP Earnings: All you need to know about PepsiCo’s Q3 2024 earnings results
PepsiCo, Inc. (NASDAQ: PEP) reported its third quarter 2024 earnings results today. Net revenue dipped 0.6% to $23.3 billion compared to the same period a year ago. Organic revenue growth